Key result
Dexmedetomidine significantly attenuated the inflammatory response, lowering IL-6 and INF-ɤ levels during and after cardiopulmonary bypass compared to normal saline.
Why the study?
Cardiopulmonary bypass triggers an inflammatory response affecting multiple organs, and the effect of dexmedetomidine on inflammatory markers during pediatric open-heart surgery required evaluation.
Does dexmedetomidine reduce the inflammatory response in children aged 1 to 8 years undergoing elective repair of non-cyanotic congenital heart disease with CPB?
RCT (n=61)
randomly assigned
Does dexmedetomidine reduce the inflammatory response in children aged 1 to 8 years undergoing elective repair of non-cyanotic congenital heart disease with CPB?
Dexmedetomidine significantly attenuates the inflammatory response and reduces the need for inotropic support and mechanical ventilation in children undergoing repair of non-cyanotic congenital heart disease.
No takes yet. Share an insight, caveat, or question.
Dexmedetomidine attenuates inflammation during pediatric non-cyanotic CHD repair with CPB; extends RCT evidence to this population.
Abdelrahman et al. (2020) conducted an RCT in non-cyanotic congenital heart disease (n=61). Dexmedetomidine vs. normal saline was evaluated on interleukin-6 (IL-6) and interferon-gamma (INF-ɤ) levels. Dexmedetomidine significantly attenuated the inflammatory response, lowering IL-6 and INF-ɤ levels during and after cardiopulmonary bypass compared to normal saline.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: